Icecure Medical
IceCure Medical Ltd, a commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers ProSense system, a single probe system for the treatment of malignant breast tumors, as well as associated disposables; and IceSense3 syst… Read more
Icecure Medical (ICCM) - Total Assets
Latest total assets as of September 2025: $15.08 Million USD
Based on the latest financial reports, Icecure Medical (ICCM) holds total assets worth $15.08 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Icecure Medical - Total Assets Trend (2014–2024)
This chart illustrates how Icecure Medical’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Icecure Medical - Asset Composition Analysis
Current Asset Composition (December 2024)
Icecure Medical's total assets of $15.08 Million consist of 85.5% current assets and 14.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 60.2% |
| Accounts Receivable | $221.00K | 1.8% |
| Inventory | $1.99 Million | 15.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how Icecure Medical's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Icecure Medical's current assets represent 85.5% of total assets in 2024, a decrease from 93.7% in 2014.
- Cash Position: Cash and equivalents constituted 60.2% of total assets in 2024, down from 78.8% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is inventory at 15.8% of total assets.
Icecure Medical Competitors by Total Assets
Key competitors of Icecure Medical based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Icecure Medical - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Icecure Medical generates 0.26x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Icecure Medical is currently not profitable relative to its asset base.
Icecure Medical - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.38 | 2.67 | 2.48 |
| Quick Ratio | 1.90 | 2.27 | 2.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $7.91 Million | $ 8.34 Million | $ 5.77 Million |
Icecure Medical - Advanced Valuation Insights
This section examines the relationship between Icecure Medical's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.27 |
| Latest Market Cap to Assets Ratio | 2.17 |
| Asset Growth Rate (YoY) | -23.4% |
| Total Assets | $12.58 Million |
| Market Capitalization | $27.32 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Icecure Medical's assets at a significant premium ( 2.17x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Icecure Medical's assets decreased by 23.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Icecure Medical (2014–2024)
The table below shows the annual total assets of Icecure Medical from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $12.58 Million | -23.36% |
| 2023-12-31 | $16.41 Million | -45.64% |
| 2022-12-31 | $30.19 Million | -6.48% |
| 2021-12-31 | $32.28 Million | +212.28% |
| 2020-12-31 | $10.34 Million | +41.27% |
| 2019-12-31 | $7.32 Million | +39.27% |
| 2018-12-31 | $5.25 Million | +172.07% |
| 2017-12-31 | $1.93 Million | -41.71% |
| 2016-12-31 | $3.31 Million | -34.43% |
| 2015-12-31 | $5.05 Million | +52.82% |
| 2014-12-31 | $3.31 Million | -- |